What ferritin level indicates the need for iron infusion?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 3, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Ferritin Level for Iron Infusion

Intravenous iron should be initiated when serum ferritin is < 100 ng/mL combined with transferrin saturation < 20%, or when ferritin is < 30 ng/mL regardless of transferrin saturation. 1

Diagnostic Thresholds for IV Iron

In Patients Without Inflammation

  • Ferritin < 30 ng/mL confirms absolute iron deficiency and warrants IV iron consideration, particularly when oral iron has failed or is contraindicated. 1, 2
  • Transferrin saturation < 16–20% signals iron deficiency requiring treatment. 1, 2

In Patients With Inflammation or Chronic Disease

  • Ferritin < 100 ng/mL AND transferrin saturation < 20% indicates iron deficiency requiring supplementation, because inflammation elevates ferritin independently of true iron stores. 1, 3, 2
  • Ferritin values between 30–100 ng/mL with low transferrin saturation suggest combined iron deficiency and anemia of chronic disease. 1

Absolute Indications for IV Iron (First-Line Therapy)

IV iron is mandatory as first-line treatment in the following scenarios:

  • Active inflammatory bowel disease with hemoglobin < 10 g/dL, because inflammation-driven hepcidin severely impairs oral iron absorption. 1
  • Post-bariatric surgery patients, due to disrupted duodenal iron absorption mechanisms. 1
  • Chronic kidney disease patients on hemodialysis, where IV iron is the preferred route. 1, 3
  • Intolerance to ≥ 2 different oral iron formulations (e.g., ferrous sulfate and ferrous fumarate). 1
  • Failure of ferritin to improve after 4 weeks of compliant oral therapy. 1

Relative Indications for IV Iron

  • Celiac disease with inadequate response to oral iron despite strict gluten-free diet adherence. 1
  • Chronic heart failure with iron deficiency (ferritin < 100 ng/mL or 100–300 ng/mL with transferrin saturation < 20%), where IV iron improves symptoms and quality of life. 1, 4
  • Ongoing gastrointestinal blood loss exceeding oral replacement capacity. 1
  • Severe anemia (hemoglobin < 10 g/dL) requiring rapid correction, particularly with transferrin saturation < 20%. 5

Treatment Targets After IV Iron

  • Ferritin ≥ 100 ng/mL to ensure adequate iron stores and prevent rapid recurrence. 1, 5
  • Transferrin saturation ≥ 20% to confirm iron availability for erythropoiesis. 1, 3
  • Hemoglobin increase of ≈ 2 g/dL within 3–4 weeks is the expected response. 1

Special Population Considerations

Chronic Kidney Disease (Non-Dialysis)

  • Start iron when transferrin saturation ≤ 30% AND ferritin ≤ 500 ng/mL in patients not receiving erythropoiesis-stimulating agents. 1
  • In CKD with hemoglobin < 11 g/dL, maintain ferritin ≥ 100 ng/mL and transferrin saturation ≥ 20%. 1

Inflammatory Bowel Disease

  • Re-initiate iron therapy when ferritin drops below 100 ng/mL or hemoglobin falls below 12 g/dL (women) or 13 g/dL (men). 1

Menorrhagia with Severe Anemia

  • IV iron is first-line when hemoglobin < 10 g/dL with transferrin saturation < 20%, as ongoing blood loss exceeds oral replacement capacity. 5
  • Maintenance IV iron every 3–6 months is typically required until definitive menorrhagia treatment. 5

Preferred IV Iron Formulations

  • Ferric carboxymaltose: 750–1000 mg per 15-minute infusion; two doses ≥ 7 days apart provide 1500 mg total. 1
  • Ferric derisomaltose: 1000 mg as a single infusion. 1
  • Avoid iron dextran as first-line due to higher anaphylaxis risk (0.6–0.7%). 1

Critical Pitfalls to Avoid

  • Do not use ferritin alone to diagnose iron deficiency in inflammatory conditions; always combine with transferrin saturation. 1, 3
  • Do not apply general population ferritin cutoffs (< 15 ng/mL) to patients with chronic disease; use the higher threshold of < 100 ng/mL. 1, 3
  • Do not continue oral iron beyond 4 weeks without hemoglobin improvement; switch to IV iron. 1
  • Do not use oral iron in active IBD with hemoglobin < 10 g/dL; IV iron is mandatory. 1

References

Guideline

Treatment of Iron Deficiency Anemia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Diagnosis and Management of Iron Deficiency in CKD: A Summary of the NICE Guideline Recommendations and Their Rationale.

American journal of kidney diseases : the official journal of the National Kidney Foundation, 2016

Research

Criteria for Iron Deficiency in Patients With Heart Failure.

Journal of the American College of Cardiology, 2022

Guideline

Medical Necessity Determination for Iron Deficiency Anemia with Menorrhagia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.